Waiting For Biosimilars: From Manufacturing To Litigation, Stakeholders Prepare For U.S. Market
Executive Summary
Leading players in the biosimilars realm discuss possible roadblocks to development, the battle over naming and substitution, and strategies to avoid the patent litigation dance.